SynthesisFrontiers in endocrinology2026
The cross-cultural and chronological evolution of the kidney-bone relationship: from ancient medical insights to modern molecular endocrinology.
Synthesis in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The kidney-bone axis constitutes a conserved bidirectional endocrine network that orchestrates skeletal remodeling and systemic mineral homeostasis. Its dysregulation underlies chronic kidney disease-mineral and bone disorder (CKD-MBD), renal osteodystrophy, secondary hyperparathyroidism, and associated vascular calcification, markedly elevating fracture and cardiovascular mortality risks. This review offers a unique cross-cultural and chronological synthesis of the kidney-bone relationship, bridging ancient medical insights with modern molecular endocrinology. Horizontally, we systematically compare the "kidney governing bones" doctrine in Traditional Chinese Medicine (TCM), ancient Greek humoral theory, and Ayurvedic Asthi Dhatu concept, revealing their shared holistic visceral-skeletal paradigm as the primitive prototype of contemporary multi-organ crosstalk, while highlighting distinct interpretive and therapeutic frameworks. Vertically, modern research is delineated into three developmental stages: (1) clinical-pathological observation of renal osteodystrophy and vitamin D-PTH disturbances (19th-early 20th century); (2) core molecular endocrine discoveries centered on the FGF23-Klotho, vitamin D, and OPG/RANKL/PTH signaling axes; and (3) expansion to novel multi-organ networks involving gut microbiota-derived uremic toxins, exosomes, and O-GlcNAc modification. We further summarize the multi-target mechanisms of kidney-tonifying TCM formulas (e.g., Zuogui Pill, Gushudan) and Western interventions, critically analyze translational bottlenecks-including biomarker limitations, stratified therapy challenges, and insufficient high-level clinical evidence-and propose integrated Chinese-Western strategies, multi-omics precision biomarkers, and cross-cultural theoretical fusion to advance personalized management of CKD-MBD and related metabolic bone diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.